The abstract is read at the publisher; the summary is JClub's.
GLP-1 receptor agonists are linked to reduced alcohol consumption and alcohol cue brain reactivity in people with alcohol use disorder, especially those with overweight or obesity.
- Why it matters: AUD has limited pharmacological options, and clinicians need novel molecular targets supported by converging clinical and mechanistic evidence.
- What they did: This narrative review synthesizes registry studies, target trial emulation, real-world data, case reports, preclinical work in mice, rats, and nonhuman primates, and 3 randomized controlled trials in AUD.
- The result: Across observational analyses and the 3 randomized trials, GLP-1RA use is associated with lower alcohol intake and cue reactivity, supporting a mechanistically novel strategy that needs larger, long-term trials.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.